Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

May 01, 2021; Volume 18,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Andolfo, Annapaola

    1. You have access
      A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer
      Denise Drago, Annapaola Andolfo, Ettore Mosca, Alessandro Orro, Luigi Nocera, Vito Cucchiara, Matteo Bellone, Francesco Montorsi and Alberto Briganti
      Cancer Biology & Medicine May 2021, 18 (2) 604-615; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0617
  2. Ba, Yi

    1. You have access
      The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinoma
      Yan Song, Juxiang Xiao, Wentao Fang, Ping Lu, Qingxia Fan, Yongqian Shu, Jifeng Feng, Shu Zhang, Yi Ba, Yang Zhao, Ying Liu, Chunmei Bai, Yuxian Bai, Yong Tang, Jie He and Jing Huang
      Cancer Biology & Medicine May 2021, 18 (2) 562-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0187
  3. Bai, Chunmei

    1. You have access
      The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinoma
      Yan Song, Juxiang Xiao, Wentao Fang, Ping Lu, Qingxia Fan, Yongqian Shu, Jifeng Feng, Shu Zhang, Yi Ba, Yang Zhao, Ying Liu, Chunmei Bai, Yuxian Bai, Yong Tang, Jie He and Jing Huang
      Cancer Biology & Medicine May 2021, 18 (2) 562-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0187
  4. Bai, Jie

    1. You have access
      Stimuli-responsive nanocarriers for therapeutic applications in cancer
      Xubo Zhao, Jie Bai and Wenjing Yang
      Cancer Biology & Medicine May 2021, 18 (2) 319-335; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0496
  5. Bai, Yuxian

    1. You have access
      The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinoma
      Yan Song, Juxiang Xiao, Wentao Fang, Ping Lu, Qingxia Fan, Yongqian Shu, Jifeng Feng, Shu Zhang, Yi Ba, Yang Zhao, Ying Liu, Chunmei Bai, Yuxian Bai, Yong Tang, Jie He and Jing Huang
      Cancer Biology & Medicine May 2021, 18 (2) 562-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0187
  6. Barbieri, Elena

    1. You have access
      BRCA mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees
      Laura Cortesi, Federica Domati, Annalisa Guida, Isabella Marchi, Angela Toss, Elena Barbieri, Luigi Marcheselli, Marta Venturelli, Simonetta Piana, Claudia Cirilli and Massimo Federico
      Cancer Biology & Medicine May 2021, 18 (2) 470-476; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0481
  7. Bassi, Massimo

    1. You have access
      Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas
      Giacomo Miserocchi, Claudia Cocchi, Alessandro De Vita, Chiara Liverani, Chiara Spadazzi, Sebastiano Calpona, Giandomenico Di Menna, Massimo Bassi, Giuseppe Meccariello, Giovanni De Luca, Angelo Campobassi, Maria Maddalena Tumedei, Alberto Bongiovanni, Valentina Fausti, Franco Cotelli, Toni Ibrahim and Laura Mercatali
      Cancer Biology & Medicine May 2021, 18 (2) 502-516; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0482
  8. Bellone, Matteo

    1. You have access
      A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer
      Denise Drago, Annapaola Andolfo, Ettore Mosca, Alessandro Orro, Luigi Nocera, Vito Cucchiara, Matteo Bellone, Francesco Montorsi and Alberto Briganti
      Cancer Biology & Medicine May 2021, 18 (2) 604-615; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0617
  9. Bongiovanni, Alberto

    1. You have access
      Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas
      Giacomo Miserocchi, Claudia Cocchi, Alessandro De Vita, Chiara Liverani, Chiara Spadazzi, Sebastiano Calpona, Giandomenico Di Menna, Massimo Bassi, Giuseppe Meccariello, Giovanni De Luca, Angelo Campobassi, Maria Maddalena Tumedei, Alberto Bongiovanni, Valentina Fausti, Franco Cotelli, Toni Ibrahim and Laura Mercatali
      Cancer Biology & Medicine May 2021, 18 (2) 502-516; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0482
  10. Briganti, Alberto

    1. You have access
      A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer
      Denise Drago, Annapaola Andolfo, Ettore Mosca, Alessandro Orro, Luigi Nocera, Vito Cucchiara, Matteo Bellone, Francesco Montorsi and Alberto Briganti
      Cancer Biology & Medicine May 2021, 18 (2) 604-615; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0617
« Previous (Pages : 1 2 3 4 5 6 ... 19) Next »
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 18 (2)
Cancer Biology & Medicine
Vol. 18, Issue 2
1 May 2021
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire